Recro Pharma (REPH) Restructures Acute Care Segment, Updates FY Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/18/2026

1. VRNS
2. CRWV
3. JBHT
4. TSLA
5. SCHW
6. GPRK
7. TRV
8. TFC
9. NEST:IN
10. AA

Go back to Recro Pharma (REPH) Restructures Acute Care Segment, Updates FY Guidance

Recro Pharma Restructures Acute Care Segment While Continuing To Execute on Strong CDMO Segment Performance

April 3, 2019 4:05 PM EDT

Implements Plan to Reduce Acute Care Segment Staff

CDMO Segment Continues Strong Performance; Company Increases Revenue, Operating Income and EBITDA, as Adjusted* Guidance for 2019

Expects to Become Cash Flow Breakeven During Q3; Cash Flow Positive Second Half of 2019

Plans to Seek Strategic Partner for Commercialization of IV Meloxicam

MALVERN, Pa., April 03, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH), a revenue generating specialty pharmaceutical company with a high-performing contract development and manufacturing (CDMO)... More